A phase I, open label study to evaluate the drug-drug interaction between Glecaprevir + Pibrentasvir with digoxin in healthy volunteers
Latest Information Update: 25 Apr 2016
At a glance
- Drugs Glecaprevir (Primary) ; Pibrentasvir (Primary) ; Digoxin
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors AbbVie
Most Recent Events
- 25 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics